Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Honda

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The World Allergy Organization Journal|March 6, 2024
Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trialDaisuke Honda, Michihiro Hide, Tomoo Fukuda, et al.
The World Allergy Organization Journal|March 1, 2021
Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedemaIsao Ohsawa, Atsushi Fukunaga, Shinya Imamura, et al.
Kidney International|January 18, 2013
p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidaseHiroshi Watanabe, Yohei Miyamoto, Daisuke Honda, et al.
Allergy|November 28, 2020
Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trialIsao Ohsawa, Daisuke Honda, Yusuke Suzuki, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The World Allergy Organization Journal|March 6, 2024
Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trialDaisuke Honda, Michihiro Hide, Tomoo Fukuda, et al.
The World Allergy Organization Journal|March 1, 2021
Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedemaIsao Ohsawa, Atsushi Fukunaga, Shinya Imamura, et al.
Kidney International|January 18, 2013
p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidaseHiroshi Watanabe, Yohei Miyamoto, Daisuke Honda, et al.
Allergy|November 28, 2020
Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trialIsao Ohsawa, Daisuke Honda, Yusuke Suzuki, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
Pageof 5